Related references
Note: Only part of the references are listed.Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells
Sarah K. Tasian et al.
LEUKEMIA (2019)
Optimal-Transport Analysis of Single-Cell Gene Expression Identifies Developmental Trajectories in Reprogramming (vol 176, pg 928, 2019)
Geoffrey Schiebinger et al.
CELL (2019)
De Novo PITX1 Expression Controls Bi-Stable Transcriptional Circuits to Govern Self-Renewal and Differentiation in Squamous Cell Carcinoma
Ana Sastre-Perona et al.
CELL STEM CELL (2019)
Cell competition during reprogramming gives rise to dominant clones
Nika Shakiba et al.
SCIENCE (2019)
Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas
Meritxell Carrio et al.
STEM CELL REPORTS (2019)
Reprogramming identifies functionally distinct stages of clonal evolution in myelodysplastic syndromes
Jasper Hsu et al.
BLOOD (2019)
Cell Reprogramming: The Many Roads to Success
Begum Aydin et al.
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, VOL 35 (2019)
Structural Features of Transcription Factors Associating with Nucleosome Binding
Meilin Fernandez Garcia et al.
MOLECULAR CELL (2019)
Epigenetic reprogramming of primary pancreatic cancer cells counteracts their in vivo tumourigenicity
Reyhaneh Khoshchehreh et al.
ONCOGENE (2019)
Prevention and Reversion of Pancreatic Tumorigenesis through a Differentiation-Based Mechanism
Nathan M. Krah et al.
DEVELOPMENTAL CELL (2019)
KLF4 is involved in the organization and regulation of pluripotency-associated three-dimensional enhancer networks
Dafne Campigli Di Giammartino et al.
NATURE CELL BIOLOGY (2019)
Skewed megakaryopoiesis in human induced pluripotent stemcell-derived haematopoietic progenitor cells harbouring calreticulin mutations
Hiraku Takei et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Cellular trajectories and molecular mechanisms of iPSC reprogramming
Effie Apostolou et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2018)
Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL
Alyssa L. Gagne et al.
STEM CELL RESEARCH (2018)
In vivo reprogramming drives Kras-induced cancer development
Hirofumi Shibata et al.
NATURE COMMUNICATIONS (2018)
ADAM8 Is an Antigen of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia Cells Identified by Patient-Derived Induced Pluripotent Stem Cells
Masashi Miyauchi et al.
STEM CELL REPORTS (2018)
BAK/BAX-Mediated Apoptosis Is a Myc-Induced Roadblock to Reprogramming
Esther J. Y. Kim et al.
STEM CELL REPORTS (2018)
Impact of cytosine methylation on DNA binding specificities of human transcription factors
Yimeng Yin et al.
SCIENCE (2017)
Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers
Jungsun Kim et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Generation and characterization of a human induced pluripotent stem (iPS) cell line derived from an acute myeloid leukemia patient evolving from primary myelofibrosis carrying the CALR 52 bp deletion and the ASXL1 p.R693X mutation
Cintia E. Gomez Limia et al.
STEM CELL RESEARCH (2017)
Brief Report: Human Acute Myeloid Leukemia Reprogramming to Pluripotency Is a Rare Event and Selects for Patient Hematopoietic Cells Devoid of Leukemic Mutations
Jong-Hee Lee et al.
STEM CELLS (2017)
OCT4 and SOX2 Work as Transcriptional Activators in Reprogramming Human Fibroblasts
Santosh Narayan et al.
CELL REPORTS (2017)
Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response
Mathias Bernhardt et al.
STEM CELL REPORTS (2017)
Transient and Permanent Reconfiguration of Chromatin and Transcription Factor Occupancy Drive Reprogramming
Anja S. Knaupp et al.
CELL STEM CELL (2017)
Chromatin Accessibility Dynamics during iPSC Reprogramming
Dongwei Li et al.
CELL STEM CELL (2017)
Human AML-iPSCs Reacquire Leukemic Properties after Differentiation and Model Clonal Variation of Disease
Mark P. Chao et al.
CELL STEM CELL (2017)
Stage-Specific Human Induced Pluripotent Stem Cells Map the Progression of Myeloid Transformation to Transplantable Leukemia
Andriana G. Kotini et al.
CELL STEM CELL (2017)
KLF4 Is Essential for Induction of Cellular Identity Change and Acinar-to-Ductal Reprogramming during Early Pancreatic Carcinogenesis
Daoyan Wei et al.
CANCER CELL (2016)
Patient-derived induced pluripotent stem cells in cancer research and precision oncology
Eirini P. Papapetrou
NATURE MEDICINE (2016)
Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells
Nathalie Knappe et al.
STEM CELLS (2016)
Epigenetic Determinants of Cancer
Stephen B. Baylin et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2016)
Hierarchical Oct4 Binding in Concert with Primed Epigenetic Rearrangements during Somatic Cell Reprogramming
Jun Chen et al.
CELL REPORTS (2016)
Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency
Alvaro Munoz-Lopez et al.
STEM CELL REPORTS (2016)
Pioneer Transcription Factors Target Partial DNA Motifs on Nucleosomes to Initiate Reprogramming
Abdenour Soufi et al.
CELL (2015)
Modeling Familial Cancer with Induced Pluripotent Stem Cells
Dung-Fang Lee et al.
CELL (2015)
Deterministic Restriction on Pluripotent State Dissolution by Cell-Cycle Pathways
Kevin Andrew Uy Gonzales et al.
CELL (2015)
A Highly Optimized Protocol for Reprogramming Cancer Cells to Pluripotency Using Nonviral Plasmid Vectors
Hongzhi Zhao et al.
CELLULAR REPROGRAMMING (2015)
Reprogramming of human cancer cells to pluripotency for models of cancer progression
Jungsun Kim et al.
EMBO JOURNAL (2015)
Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells
Andriana G. Kotini et al.
NATURE BIOTECHNOLOGY (2015)
Reprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophages
James Scott McClellan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Discovery of survival factor for primitive chronic myeloid leukemia cells using induced pluripotent stem cells
Kran Suknuntha et al.
STEM CELL RESEARCH (2015)
Dissecting the role of aberrant DNA methylation in human leukaemia
Giovanni Amabile et al.
NATURE COMMUNICATIONS (2015)
Myeloid Dysregulation in a Human Induced Pluripotent Stem Cell Model of PTPN11-Associated Juvenile Myelomonocytic Leukemia
Sonia Mulero-Navarro et al.
CELL REPORTS (2015)
Pluripotent Cell Models of Fanconi Anemia Identify the Early Pathological Defect in Human Hemoangiogenic Progenitors
Naoya M. Suzuki et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma
Nathan M. Krah et al.
ELIFE (2015)
MicroRNAs Induce Epigenetic Reprogramming and Suppress Malignant Phenotypes of Human Colon Cancer Cells
Hisataka Ogawa et al.
PLOS ONE (2015)
Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation
Kotaro Ohnishi et al.
CELL (2014)
Pioneer transcription factors in cell reprogramming
Makiko Iwafuchi-Doi et al.
GENES & DEVELOPMENT (2014)
Reprogramming of MLL-AF9 leukemia cells into pluripotent stem cells
Y. Liu et al.
LEUKEMIA (2014)
Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients
M. Sakurai et al.
LEUKEMIA (2014)
Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells
Marina Bershteyn et al.
NATURE (2014)
Genome-wide characterization of the routes to pluripotency
Samer M. I. Hussein et al.
NATURE (2014)
SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma
Soufiane Boumahdi et al.
NATURE (2014)
Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors
M. Nishi et al.
ONCOGENE (2014)
Differential Sensitivity to JAK Inhibitory Drugs by Isogenic Human Erythroblasts and Hematopoietic Progenitors Generated from Patient-Specific Induced Pluripotent Stem Cells
Zhaohui Ye et al.
STEM CELLS (2014)
Induction of pluripotency in human somatic cells via a transient state resembling primitive streak- like mesendoderm
Kazutoshi Takahashi et al.
NATURE COMMUNICATIONS (2014)
Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia
Shilpa Gandre-Babbe et al.
BLOOD (2013)
Widespread resetting of DNA methylation in glioblastoma-initiating cells suppresses malignant cellular behavior in a lineage-dependent manner
Stefan H. Stricker et al.
GENES & DEVELOPMENT (2013)
Reprogramming in vivo produces teratomas and iPS cells with totipotency features
Maria Abad et al.
NATURE (2013)
Mechanisms and models of somatic cell reprogramming
Yosef Buganim et al.
NATURE REVIEWS GENETICS (2013)
Heterozygous and Homozygous JAK2V617F States Modeled by Induced Pluripotent Stem Cells from Myeloproliferative Neoplasm Patients
Joseph Saliba et al.
PLOS ONE (2013)
C/EBPα Induces Highly Efficient Macrophage Transdifferentiation of B Lymphoma and Leukemia Cell Lines and Impairs Their Tumorigenicity
Francesca Rapino et al.
CELL REPORTS (2013)
An iPSC Line from Human Pancreatic Ductal Adenocarcinoma Undergoes Early to Invasive Stages of Pancreatic Cancer Progression
Jungsun Kim et al.
CELL REPORTS (2013)
Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples
Keiki Kumano et al.
BLOOD (2012)
Facilitators and Impediments of the Pluripotency Reprogramming Factors' Initial Engagement with the Genome
Abdenour Soufi et al.
CELL (2012)
A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells
Jose M. Polo et al.
CELL (2012)
Single-Cell Expression Analyses during Cellular Reprogramming Reveal an Early Stochastic and a Late Hierarchic Phase
Yosef Buganim et al.
CELL (2012)
Metabolic Regulation in Pluripotent Stem Cells during Reprogramming and Self-Renewal
Jin Zhang et al.
CELL STEM CELL (2012)
Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation
S. M. Kumar et al.
ONCOGENE (2012)
Pluripotency in the Embryo and in Culture
Jennifer Nichols et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
Benjamin J. Hindson et al.
ANALYTICAL CHEMISTRY (2011)
Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells
Kejin Hu et al.
BLOOD (2011)
Polycomb-Repressed Genes Have Permissive Enhancers that Initiate Reprogramming
Phillippa C. Taberlay et al.
CELL (2011)
Somatic Oxidative Bioenergetics Transitions into Pluripotency-Dependent Glycolysis to Facilitate Nuclear Reprogramming
Clifford D. L. Folmes et al.
CELL METABOLISM (2011)
Reprogramming Factor Expression Initiates Widespread Targeted Chromatin Remodeling
Richard P. Koche et al.
CELL STEM CELL (2011)
OCT4 establishes and maintains nucleosome-depleted regions that provide additional layers of epigenetic regulation of its target genes
Jueng Soo You et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Generation of iPSCs from cultured human malignant cells
Jan E. Carette et al.
BLOOD (2010)
A Myc Network Accounts for Similarities between Embryonic Stem and Cancer Cell Transcription Programs
Jonghwan Kim et al.
CELL (2010)
A Mesenchymal-to-Epithelial Transition Initiates and Is Required for the Nuclear Reprogramming of Mouse Fibroblasts
Ronghui Li et al.
CELL STEM CELL (2010)
Functional Genomics Reveals a BMP-Driven Mesenchymal-to-Epithelial Transition in the Initiation of Somatic Cell Reprogramming
Payman Samavarchi-Tehrani et al.
CELL STEM CELL (2010)
Proliferation of aneuploid human cells is limited by a p53-dependent mechanism
Sarah L. Thompson et al.
JOURNAL OF CELL BIOLOGY (2010)
Defined factors induce reprogramming of gastrointestinal cancer cells
Norikatsu Miyoshi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders
Zhaohui Ye et al.
BLOOD (2009)
Direct cell reprogramming is a stochastic process amenable to acceleration
Jacob Hanna et al.
NATURE (2009)
Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts
Akiko Doi et al.
NATURE GENETICS (2009)
Dissecting direct reprogramming through integrative genomic analysis
Tarjei S. Mikkelsen et al.
NATURE (2008)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Reprogramming metastatic tumour cells with embryonic microenvironments
Mary J. C. Hendrix et al.
NATURE REVIEWS CANCER (2007)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Mechanisms of Disease: oncogene addiction - a rationale for molecular targeting in cancer therapy
I. Bernard Weinstein et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Polycomb complexes repress developmental regulators in murine embryonic stem cells
LA Boyer et al.
NATURE (2006)
Control of developmental regulator's by polycomb in human embryonic stem cells
TI Lee et al.
CELL (2006)
Global loss of imprinting leads to widespread tumorigenesis in adult mice
TM Holm et al.
CANCER CELL (2005)
Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues
K Hochedlinger et al.
CELL (2005)
Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice
T Sakatani et al.
SCIENCE (2005)
Reprogramming of a melanoma genome by nuclear transplantation
K Hochedlinger et al.
GENES & DEVELOPMENT (2004)
Share Paper
